FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts.
about
Fibroblast growth factor signaling in skeletal development and diseaseNovel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome.The molecular and cellular basis of Apert syndrome.EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome.
P2860
FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@en
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@nl
type
label
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@en
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@nl
prefLabel
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@en
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@nl
P2093
P2860
P1476
FGFR2 mutation confers a less ...... tem cells than in fibroblasts.
@en
P2093
Felipe A A Ishiy
Hamilton Matushita
Katia Maria da Rocha
Nivaldo Alonso
Roberto Dalto Fanganiello
Rodrigo Atique
P2860
P2888
P304
P356
10.1007/S12015-011-9327-6
P577
2012-09-01T00:00:00Z